Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy could stop prostate cancer spreading, trial shows

Posted by btwatson on June 2, 2018 7:31 pm
Tags:
Categories: Uncategorized

Source: Immunotherapy could stop prostate cancer spreading, trial shows

[unable to retrieve full-text content]

  1. Immunotherapy could stop prostate cancer spreading, trial shows  The Guardian
  2. ASCO 2018: Major trial is first to show benefits of immunotherapy in some men with prostate cancer  The Institute of Cancer Research
  3. Prostate cancer immune system drug results could be ‘spectacular’  BBC News
  4. Full coverage

Published at Sat, 02 Jun 2018 17:51:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • How the Gut Microbiome Helps the Immune System Fight Melanoma - Technology Networks
    November 12, 2025
  • Stage IV melanoma survivor: An immunotherapy clinical trial saved my life - MD Anderson Cancer Center
    November 12, 2025
  • Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer - CancerNetwork
    November 11, 2025
  • Analyzing Nivolumab and Ipilimumab as HCC Therapy - Targeted Oncology
    November 11, 2025
  • ELI-002 7P Elicits Robust T-Cell Responses in KRAS+ Pancreatic Cancer - CancerNetwork
    November 11, 2025
  • Locoregional therapy combined with targeted therapy and immunotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis - Nature
    November 11, 2025
  • Signatera Guides Bladder Cancer Treatment After Surgery - Cure Today
    November 11, 2025
  • CONGRATS Trial Data of Nivolumab ± Relatlimab Highlight Clinical Value of Immunotherapy in TLS+ Soft Tissue Sarcoma - OncLive
    November 11, 2025
  • Williams Cancer Institute Presents Data on Combined Pulsed Electrical Field Ablation and Intratumoral Immunotherapy at SITC 2025 - Oncodaily
    November 11, 2025
  • FDA Approves Generic Dasatinib, Expanding Access to Key TKI - Targeted Oncology
    November 11, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com